Vinson Chan

Biparametric vs Multiparametric MRI for Prostate Cancer DiagnosisThe PRIME Diagnostic Clinical Trial jamanetwork.com/journals/jam… Investigators compared biparametric MRI (without contrast) to standard multiparametric MRI for diagnosing clinically significant #ProstateCancer in biopsy-naive men with suspected disease. Among 490 evaluable patients, biparametric MRI detected clinically significant cancer in 29.2% of men, virtually identical to multiparametric MRI at 29.6%, with differences well within the prespecified noninferiority margin. Detection of clinically insignificant cancer was also nearly identical between approaches. Importantly, 99% of scans met diagnostic quality standards. These findings suggest that biparametric MRI, a faster and less costly technique, is noninferior to multiparametric MRI and may serve as a new global standard for prostate cancer diagnosis, offering significant gains in efficiency and health system capacity. @AlexBCDNg @AquaAsif @VPanebiancoIT @R_Girometti @Tristan_Radiol @JPRadtke @ClaudiaKesch @AdrianoDiasRad @nycrobotics @tanejauro @FDeCobelli @LanceMynderse @BoesenLars @parsin276 @jleow @ffmed @GGiannarini @Nptdot @ProstateCambrdg @MarimoRossiter @ArjunSNathan @p_khetrapal @VinsonChan @aimhaider Shonit Punwani @ucl @GiorgioBre @DoctorMargolis Mark Emberton @UCLMS @giga_fra @mrsprostate Veeru Kasivisvanathan @Silke_Gillessen @AOmlin @nataliagandur @bavilima